In certain diseases, the mitral valve becomes enlarged asymmetrically, creating an uneven widening of the mitral valve. The IMR ETlogix ring, the first asymmetric ring created to treat this irregular dilatation, is designed for the unique requirements of ischemic mitral heart valve repair.
The IMR ETlogix ring was created to address the variable deformities and poor leaflet closure caused by myocardial infarction, coronary artery disease or mitral valve defects. The ring’s unique three-dimensional design helps surgically reconfigure the valve’s annulus, reducing mitral regurgitation.
The IMR ETlogix ring is part of the company's market-leading heart valve therapy franchise, which also includes a comprehensive selection of heart valve repair products, and the Carpentier-Edwards PERIMOUNT pericardial heart valve replacements – the world's most widely prescribed tissue valves. This broad portfolio of products offers patients and physicians many options for tailoring disease-specific repair and replacement therapies.
Unique Features- The first asymmetric ring created to treat asymmetric dilatation of the mitral valve.
- Made of titanium alloy, the IMR ETlogix ring features a unique 3-D design.
- The ring’s design reconfigures the valve's annulus and reduces mitral regurgitation.
